Anders Kristensson
Directeur Général chez PROSTALUND AB
Profil
Anders Kristensson is currently the Chief Executive Officer at ProstaLund AB since 2023.
Prior to this, he was the Chief Executive Officer at TikoMed AB from 2018 to 2022.
He also worked at Eli Lilly & Co. as the Managing Director-Nordics, Baltics & Egypt.
Mr. Kristensson holds an MBA from the University of Lund.
Postes actifs de Anders Kristensson
Sociétés | Poste | Début |
---|---|---|
PROSTALUND AB | Directeur Général | 01/10/2023 |
Anciens postes connus de Anders Kristensson
Sociétés | Poste | Fin |
---|---|---|
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Directeur Général | 01/11/2022 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Anders Kristensson
University of Lund | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PROSTALUND AB | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 1 |
---|---|
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Health Technology |